Skip to content

Global Startups Research & Market Intelligence REPORT

Identify Partners Series



Latest Report covering World’s Largest Number of Active Neurology Drug Developers Analysis


Top 370

Neurology Startups

Highly Innovative and Precise Report designed to Identify and Capture the Outlook of Early Stage Neurology Drug Developers present in 26 countries worldwide

Neurology Startups 2020 (Second Updated Edition)

Covers all Aspects of Neurology Startups Drug Development Intelligence


Neurology Startups 2020 Vs 2017

Updated knowledge everytime


NS 2020 is a key update over previous report NS 2017, as it covers 189 more Neurology Startups Drug Developers than the previous report. It also abandoned 69 companies, which were earlier covered in NS 2017, which were either acquired/merged or closed during the period.

largest coverage

complete intelligence at fingertips


Worldwide Extensive Coverage


Formed after 2010; with Market Valuation less then $500Mn USD


Largest Early Stage Developmental Pipeline Details

1 +

Covers exclusive Neurology focused deals, partnering with BIG Pharma, CROs etc.

Perfect B2B Solution

intelligence supercharged

Unique first in class Intelligence Report

Provides Complete Landscape on Latest Neurology Drug Development covering Emerging Technologies, Partnering and Funding Status in the Domain.

Also, Startups having proper funding, technologies and pipeline are only included. No Acquired, Merged or Dormant Stage Neurology Drug Developer is included.

Report is highly precise and designed keeping in mind to keep information intact, informative and self explanatory. Also, every piece of intelligence is cross validated.

Only facts, no guess work.

300+ Pages present complete picture of individual company’s pipeline, deals, partnering, funding etc. and outline individual startup’s core strength and stand with respect to other startups.

Report documents all Neurology focused news/deals of every startups since incorporation. Making it perfect tool for Decision Making and a big time saver too.

Compares Oranges with Oranges.

Only Active Neurology Drug Developing Startups, with no room to Diagnostic and Device companies; making data clear and impactful.

Most of the intelligence provider covers limited number of known companies, that too many of which have no links to the core title of the report. Also many renowned database too contains acquired/closed companies, thus driving final intelligence too tedious and time consuming exercise.

All our reports provides comprehensive intelligence, with largest active industry coverage and avoids investing money on other similar resources. Thus, saves lots of resources in terms of time and money, in identifying new partnering opportunities.

Each year, we publish very small number of comprehensive reports and are experts in identifying and tracking startups. We maintain our own database and track’s every individual company.

From last 10 years, our team exclusively providing marketing intelligence in field of Oncology and Neurology Drug Development.

300 pages full of insights​

Our Report Buyers

Trusted by Over 150+ Companies

(Since 2012 Onward)

Bank / Wire Transfer

During checkout, under payment method opt for wire transfer method. On completion the order you will receive an auto generated Invoice in your email, with our bank account and other wire transfer details; or directly reach out at to raise required Invoice.

Online / Credit Card

Single step one click secured Express Checkout through PayPal gateway. Report will be delivered in few minutes directly in your inbox after payment confirmation.

Identify and Partner

Prior to others

Other Reports in this Series
Neurology Startups 2017
Top 250 Neurology Startups Drug Developers established between 2010-2016.
Perfect Report to Identify and Partner first with Emerging Companies.
Neurology Startups 2020
Top 370 Neurology Startups Drug Developers established between 2010-2019.
Perfect Report to Identify and Partner first with Emerging Companies.
September 2016
December 2019